Page last updated: 2024-11-03

propranolol and Thrombocytopathy

propranolol has been researched along with Thrombocytopathy in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Platelet function was investigated in four normal volunteers, one patient with a mild form of von Willebrand disease, and one with a thrombocytopathy, all taking propranolol."3.66Some observations on the in vivo effect of propranolol on platelet aggregation and release. ( Leon, R; Pechet, L; Tiarks, CY, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leon, R1
Tiarks, CY1
Pechet, L1
Hampton, JR1
Harrison, MJ1
Honour, AJ1
Mitchell, JR1

Other Studies

2 other studies available for propranolol and Thrombocytopathy

ArticleYear
Some observations on the in vivo effect of propranolol on platelet aggregation and release.
    American journal of hematology, 1978, Volume: 5, Issue:2

    Topics: Adult; Blood Platelet Disorders; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggreg

1978
Platelet behaviour and drugs used in cardiovascular disease.
    Cardiovascular research, 1967, Volume: 1, Issue:2

    Topics: Adenine Nucleotides; Blood Platelet Disorders; Electrophoresis; Humans; In Vitro Techniques; Nitrogl

1967